liver cirrhosis post HBV
Conditions
Interventions
Sponsors
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Ages 18 to 65, regardless of gender; (2) It conforms to the western medicine diagnostic criteria of liver cirrhosis post HBV, and the TCM syndrome differentiation criteria of liver-kidney Yin deficiency syndrome, and the CTP score is 7-9 points (Grade B); (3) Patients who are taking or preparing to take Entecavir; (4) The person or his guardian agrees to participate in the randomized controlled trial and signs the informed consent.
Exclusion criteria
Exclusion criteria: (1) Liver failure; (2) Hepatitis with other hepatitis virus infection, fatty liver, long-term alcohol consumption or other chronic severe hepatitis; (3) Women who are pregnant or preparing for pregnancy, or women who are breastfeeding; (4) Severe underlying diseases: severe COPD, severe renal insufficiency, chronic congestive heart failure, etc. (5) Patients with immunodeficiency, such as malignant tumor, organ transplantation and taking immunosuppressive drugs or glucocorticoids within the last 3 months; (6) Patients participating in other clinical trials; (7) Other conditions that the researcher believes are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Child-Turcotte-Pugh score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hepatic function;blood routine examination;two pairs of semi -hepatitis;HBV DNA;B ultrasound (liver, gall bladder, pancreas, spleen); | — |
Countries
China
Contacts
Public ContactJiamei Chen
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed